Codiak BioSciences Inc
Biotechnology
Healthcare
CDAK
22.49 M shares
NASDAQ US
traded
12 Sep 2022
listed
yes
open
1.76
52 week high
19.14
high
1.78
52 week low
1.67
low
1.67
growth
-90.29 %
previous Close
1.79
P/E ratio
market cap
55.52 M
div yield
0
usd
Jun 2022
qoq
revenue
13.15 M
3.47 %
net incoming
-6.78 M
15.61 %
eps
0.00 %
16.67 %
eps surprise
64.29 %
net profit margin
-51.54 %
11.00 %
operating incoming
-7.02 M
14.96 %
net change in cash
-14.71 M
28.05 %
cash on hand
41.79 M
-26.04 %
cost of revenue
0.00 %
top top